CIK 0001853921 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Scribe Therapeutics, Inc.
Sign in to watch- Ticker
- SCTX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 822157847
- Phone
- 510-454-0213
- Business address
- 1150 MARINA VILLAGE PKWY, ALAMEDA, CA, 94501
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13D Stake Beneficial Ownership Report
- SCHEDULE 13D Stake Beneficial Ownership Report
- 4 Open-market buy 10% owner bought 333,333 shares at $15.00 ($4,999,995)
- 4 Open-market buy Director bought 1,000,000 shares at $15.00 ($15,000,000)
- 4 Open-market buy Director bought 1,000,000 shares at $15.00 ($15,000,000)
- SCHEDULE 13D Stake Beneficial Ownership Report
- 4 Conversion 10% owner acquired 12,511 shares (conversion)
- 4 Open-market buy Director bought 2,391,238 shares at an average $15.16 ($36,259,761)
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Chief Business Officer bought 3,000 shares at $15.00 ($45,000)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Chief Financial Officer bought 2,666 shares at $15.00 ($39,990)
- 4 Derivatives Options or other derivatives
- 8-K Event Bylaws or fiscal year change
Page 1 of 3 · 46 filings